Related Experiment Video
Updated: Jul 7, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Asthma costs and utilization in a managed care organization
Robert S Zeiger1, Joel W Hay, Richard Contreras
1Department of Allergy, Kaiser Permanente Medical Center, 7060 Clairemont Mesa Blvd, San Diego, CA 92111, USA. robert.s.zeiger@kp.org
Single controller inhaled corticosteroid (ICS) therapy is associated with lower medical costs and healthcare utilization for asthma patients compared to other treatment regimens. This finding highlights the cost-effectiveness of ICS as a primary asthma management strategy.
Area of Science:
- Pulmonary Medicine
- Health Economics
- Pharmacoeconomics
Background:
- Asthma management costs and healthcare utilization patterns require further investigation.
- Understanding treatment variations is crucial for optimizing patient care and resource allocation.
Purpose of the Study:
- To compare the medical costs and utilization of single controller inhaled corticosteroids (ICS) against other asthma drug regimens.
- To evaluate the economic impact of different asthma treatment strategies.
Main Methods:
- Utilized administrative electronic databases for direct medical costs and utilization data.
- Analyzed data from continuously enrolled asthma patients aged 5+ with drug coverage.
- Categorized 96,631 patients into 14 asthma drug groups based on 2003 prescriptions, assessing 2004 costs and utilization, adjusted for covariates.
Main Results:
- Single controller ICS demonstrated significantly lower total direct medical costs and asthma drug costs compared to leukotriene modifiers, long-acting beta-agonists, theophylline, and most combination controllers.
- Patients on single controller ICS experienced significantly lower asthma-related healthcare utilization versus leukotriene modifiers and combination controllers.
Conclusions:
- Single controller ICS therapy is linked to substantially reduced direct medical costs and asthma-related utilization in the year following prescription.
- This suggests inhaled corticosteroids are a cost-effective first-line treatment for asthma management.
Related Concept Videos
Asthma-IV: Nursing Management
First, in...
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma I: Introduction
Asthma-I: Introduction
